Evolution and Impact of Subclonal Mutations in Papillary Thyroid Cancer-Reference-Cited by-同舟云学术

Evolution and Impact of Subclonal Mutations in Papillary Thyroid Cancer

Published:2019-11 Issue:5 Volume:105 Page:959-973
ISSN:0002-9297
Container-title:The American Journal of Human Genetics
language:en
Short-container-title:The American Journal of Human Genetics

Author:

Masoodi Tariq,Siraj Abdul K.,Siraj Sarah,Azam Saud,Qadri Zeeshan,Parvathareddy Sandeep K.,Al-Sobhi Saif S.,AlDawish Mohammed,Alkuraya Fowzan S.,Al-Kuraya Khawla S.

Funder

Saudi Government to the Thyroid Cancer Genome Project

Publisher

Elsevier BV

Subject

Genetics(clinical),Genetics

Reference67 articles.

1. Systematic review of trends in the incidence rates of thyroid cancer;Wiltshire;Thyroid,2016

2. Thyroid cancer in Saudi Arabia: a histopathological and outcome study;Alzahrani;Int. J. Endocrinol.,2017

3. Recurrence of papillary thyroid cancer after optimized surgery;Grant;Gland Surg.,2015

4. Both BRAF V600E mutation and older age (≥ 65 years) are associated with recurrent papillary thyroid cancer;Howell;Ann. Surg. Oncol.,2011

5. Impact of lymph node metastases identified on central neck dissection (CND) on the recurrence of papillary thyroid cancer: potential role of BRAFV600E mutation in defining CND;Alzahrani;Endocr. Relat. Cancer,2013

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploration of the prognostic value of methylation regulators related to m5C in papillary thyroid carcinoma;Medicine;2024-06-21

2. Mapping recurrent mosaic copy number variation in human neurons;Nature Communications;2024-05-17

3. Genetic alterations and allele frequency of BRAF V600E and TERT mutation in papillary thyroid carcinoma with intermediate-to-high recurrence risk: a retrospective study;Clinical and Experimental Medicine;2024-04-12

4. A Phase 2 Study of Encorafenib in Combination with Binimetinib in Patients with Metastatic BRAF-Mutated Thyroid Cancer in Japan;Thyroid®;2024-03-14

5. Whole Exome-Wide Association Identifies Rare Variants in GALNT9 Associated with Middle Eastern Papillary Thyroid Carcinoma Risk;Cancers;2023-08-24